United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 3, 2026 · Filed Jun 4, 2026

On Jun 3, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$547.61 for US$5.2M under a trading plan, leaving 40,513 shares. Filed Jun 4, 2026 (Form 4).

Sold
9,500 shares
Price
US$547.61 average (US$543.89 to US$551.97)
Value
US$5.2M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 3, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 3, 2026Common StockSale401US$543.8949,612Direct
Jun 3, 2026Common StockSale1,139US$545.2248,473Direct
Jun 3, 2026Common StockSale1,050US$546.0147,423Direct
Jun 3, 2026Common StockSale1,664US$546.9645,759Direct
Jun 3, 2026Common StockSale2,226US$548.0443,533Direct
Jun 3, 2026Common StockSale1,956US$549.1541,577Direct
Jun 3, 2026Common StockSale842US$550.0640,735Direct
Jun 3, 2026Common StockSale80US$551.2340,655Direct
Jun 3, 2026Common StockSale142US$551.9740,513Direct

Source

View original at SEC

Related